In 2023, NHS England appointed Octapharma as the sole manufacturer for the Plasma for Medicines (PfM) programme, providing immunoglobulins and albumin made from UK-donated plasma until at least 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback